Lubenow, Norbert <br/><br/>
Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocytopenia in patients receiving danaparoid, ancrod, and/or coumarin explain the rapid shift in clinical practice during the 1990s.  [electronic resource] 

 -  Thrombosis research  2006 
 - 507-15 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0049-3848 
<br/><br/><label>Standard No.: </label>10.1016/j.thromres.2005.04.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Ancrod--administration & dosage<br/>Canada<br/>Chondroitin Sulfates--administration & dosage<br/>Cohort Studies<br/>Coumarins--administration & dosage<br/>Dermatan Sulfate--administration & dosage<br/>Female<br/>Germany<br/>Heparin--adverse effects<br/>Heparitin Sulfate--administration & dosage<br/>Humans<br/>Male<br/>Outcome Assessment, Health Care<br/>Platelet Count<br/>Practice Patterns, Physicians'--trends<br/>Retrospective Studies<br/>Survival Analysis<br/>Thrombocytopenia--chemically induced